NOVAVAX INC (NVAX) Earnings
NOVAVAX INC's most recently reported earnings, recent earnings filings (8-K) and headline annual financials, sourced from SEC EDGAR.
Next earnings (estimated)
Around Feb 25, 2027
From past filing pattern
Get notified when NVAX reports →Last reported earnings
Nov 5, 2026
From the latest earnings 8-K
Revenue • FY2025
$1.12B
▲ 64.7%YoY
Diluted EPS • FY2025
$2.58
▲ 309.8%YoY
Reported earnings dates are based on the latest 8-K (Item 2.02) filings. The next earnings date is an estimate projected from NVAX's historical reporting pattern, not a company-confirmed date.
Headline financials
| Period | Revenue | Net income | Gross profit | Dil. EPS | Free cash flow | Op. margin | Rev. growth |
|---|---|---|---|---|---|---|---|
| FY2025 | $1.12B | $440.3M | $1.05B | $2.58 | -$250.19M | 40.3% | +64.7% |
| FY2024 | $682.16M | -$187.5M | $479.42M | -$1.23 | -$100.32M | -36.5% | -30.6% |
| FY2023 | $983.71M | -$545.06M | $639.94M | -$5.41 | -$767.74M | -57.6% | -50.4% |
| FY2022 | $1.98B | -$657.94M | $1.08B | -$8.42 | -$504.99M | -32.5% | +72.9% |
Recent earnings filings
| Filed | Form | Accession |
|---|---|---|
| Nov 5, 2026 | 8-K (2.02) | 0001000694-26-000021EDGAR |
| Aug 6, 2026 | 8-K (2.02) | 0001000694-26-000019EDGAR |
| May 6, 2026 | 8-K (2.02) | 0001628280-26-030924EDGAR |
| Feb 26, 2026 | 8-K (2.02) | 0001000694-26-000011EDGAR |
| Jan 12, 2026 | 8-K (2.02) | 0001104659-26-002725EDGAR |
| Nov 6, 2025 | 8-K (2.02) | 0001000694-25-000048EDGAR |
| Aug 6, 2025 | 8-K (2.02) | 0001000694-25-000031EDGAR |
| May 8, 2025 | 8-K (2.02) | 0001000694-25-000024EDGAR |
Earnings for companies related to NVAX
Never miss a NVAX filing.
Get an email when NVAX files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.
Free foreverNo account requiredOne-click unsubscribe
Data as of Nov 5, 2026Source: SEC EDGAR.